Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-12-16Clinical Trial Update: The Effects of Strawberries on Blood Pressure in Postmenopausal Women [NA]
A completed clinical trial from Florida State University evaluated the effects of strawberry consumption on blood pressure in postmenopausal…
-
FDA approval · 2016-12-15FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic fixed-dose combination of telmisartan and hydrochlorothiazide for hypertension from Auro…
-
CLINICAL_TRIALS research · 2016-12-14Clinical Trial Update: Acute Effects of Different Exercises on Blood Pressure in Hypertensive Subjects [NA]
This entry provides an update on a clinical trial studying how various exercises acutely affect blood pressure in people with hypertension.
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Effect of Smart Phone Based Telemonitoring on Blood Pressure Among Hypertensive Patients in Primary Care [NA]
Completed clinical trial assessing whether smartphone-based telemonitoring improves blood pressure control in hypertensive patients in prima…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Study of the Long-term Effects of Exercise on Heath Indicators in Older People [NA]
A completed clinical trial update reporting the long-term effects of exercise on health indicators in older adults, including hypertension, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-12-09FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA issued a supplemental approval for AZOR (amlodipine besylate and olmesartan medoxomil) by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Influence of Insulin on BP Change During Adolescence
Completed clinical trial evaluating how insulin influences blood pressure changes during adolescence.
-
FDA approval · 2016-12-06FDA Approved: IRBESARTAN — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's supplemental application for IRBESARTAN, enabling the generic ARB formulation to be marketed …
-
FDA approval · 2016-12-06FDA Approved: IRBESARTAN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for IRBESARTAN filed by Camber Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2016-12-06Clinical Trial Update: Complications in Hypertension and Obesity
This clinical trial update reports ongoing research into complications associated with metabolic syndrome, hypertension, obesity, dyslipidem…
-
FDA approval · 2016-12-02FDA Approved: IRBESARTAN — Supplemental Application (AvKARE)
FDA approved a supplemental application for IRBESARTAN from AvKARE.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: The Effects of Apple Derived Flavanols on Cardiovascular Disease Risk (FLAVASCULAR Study) [NA]
The FLAVASCULAR trial evaluating apple-derived flavanols for cardiovascular disease risk has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Bariatric Surgery, Arterial Stiffness and Target Organ Damage Study (BASTOD)
The BASTOD trial, now completed, evaluated the effects of bariatric surgery on arterial stiffness and target organ damage in individuals wit…
-
CLINICAL_TRIALS research · 2016-12-01Clinical Trial Update: Epidemiologic Study to Evaluate the Proportion of Cardiovascular Disease Risk Factors in Korean Hypertensive Patients
A completed epidemiologic study sponsored by GlaxoSmithKline to evaluate the proportion of cardiovascular disease risk factors in Korean pat…
-
FDA approval · 2016-11-30FDA Approved: METOPROLOL TARTRATE — Supplemental Application (TRUPHARMA LLC)
FDA approved a supplemental application for metoprolol tartrate submitted by TRUPHARMA LLC. This action approves the supplemental filing for…
-
FDA approval · 2016-11-30FDA Approved: GUANFACINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s supplemental application for guanfacine, enabling continued marketing of a generic product. This act…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Impact of Best Practice Alerts in Cardiology Outpatient Clinics [NA]
Duke University conducted a completed clinical trial assessing the impact of best practice alerts on patient care in cardiology outpatient c…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Add-on to Micamlo BP Trial [Phase 3]
Phase 3 add-on trial results for Micamlo in hypertension were completed and results posted.
-
CLINICAL_TRIALS research · 2016-11-29Clinical Trial Update: Unsupervised Physical Activity in Elderly [NA]
A completed clinical trial evaluating unsupervised physical activity in elderly individuals with hypertension.
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Racial Variation in ACE--Genetic and Physiologic Bases
An update on a completed Vanderbilt-sponsored clinical trial investigating racial differences in ACE genetics and physiology.
-
FDA approval · 2016-11-25FDA Approved: METOPROLOL SUCCINATE — Original Application (Actavis Pharma, Inc.)
FDA approved the original application for metoprolol succinate, establishing a generic sustained-release formulation from Actavis Pharma, In…
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Integrated Population Program for Diabetic Kidney Disease [NA]
A completed clinical trial update for an Integrated Population Program targeting Diabetic Kidney Disease. The update notes Uncontrolled Hype…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Aliskiren in elderly patients with hypertension has completed.
-
FDA approval · 2016-11-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
FDA approved a supplemental application for verapamil hydrochloride from Wilshire Pharmaceuticals, Inc., updating the existing NDA.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of a fixed-dose combination of valsartan and hydrochlorothiazide in hypertensive patients …